To furnish direct proof which the peculiar enhancement of catecholaminergic action inside the brain in animals dealt with with a small dose of (−)deprenyl is unrelated to MAO inhibition, we designed in the early '90s a spouse and children of deprenyl analogues devoid of the MAO-B inhibitory impact (Knoll et https://dallasmmhcv.rimmablog.com/29732419/an-unbiased-view-of-ppap-hcl